Nantes Université, CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, CNRS UMS 3556, F-44000 Nantes, France; INSERM, Centre de Recherche en Transplantation et Immunologie UMR1064, Nantes Université, Nantes, France.
genOway, 69007 Lyon, France.
Stem Cell Reports. 2024 Sep 10;19(9):1255-1263. doi: 10.1016/j.stemcr.2024.07.005. Epub 2024 Aug 15.
Human immune system (HIS) mice generated using human CD34 hematopoietic stem cells serve as a pivotal model for the in vivo evaluation of immunotherapies for humans. Yet, HIS mice possess certain limitations. Rats, due to their size and comprehensive immune system, hold promise for translational experiments. Here, we describe an efficacious method for long-term immune humanization, through intrahepatic injection of hCD34 cells in newborn immunodeficient rats expressing human SIRPα. In contrast to HIS mice and similar to humans, HIS rats showed in blood a predominance of T cells, followed by B cells. Immune humanization was also high in central and secondary lymphoid organs. HIS rats treated with the anti-human CD3 antibody were depleted of human T cells, and human cytokines were detected in sera. We describe for the first time a method to efficiently generate HIS rats. HIS rats have the potential to be a useful model for translational immunology.
利用人源 CD34 造血干细胞生成的人免疫系统(HIS)小鼠可作为评估人类免疫疗法的体内模型。然而,HIS 小鼠存在某些局限性。由于大鼠的体型和全面的免疫系统,它们在转化实验中具有一定的应用前景。在这里,我们描述了一种通过在表达人 SIRPα 的新生免疫缺陷大鼠肝内注射 hCD34 细胞实现长期免疫人源化的有效方法。与 HIS 小鼠类似,与人类不同的是,HIS 大鼠的血液中 T 细胞占主导地位,其次是 B 细胞。免疫人源化在中枢和次级淋巴器官中也很高。用抗人 CD3 抗体处理的 HIS 大鼠耗尽了人 T 细胞,并且在血清中检测到了人细胞因子。我们首次描述了一种有效生成 HIS 大鼠的方法。HIS 大鼠有可能成为转化免疫学的有用模型。